NuVasive Boosts Artificial Disc Development, Stock; OTC Index Rises 15%
This article was originally published in The Gray Sheet
Executive Summary
NuVasive will use profits gained from a series of 510(k)-cleared spinal devices to fuel artificial disc and nucleus replacement development in 2006
You may also be interested in...
Intuitive Surgical shows no slowing
Growth of robotic surgery systems firm continues to soar with second quarter sales of $87 mil., up 65% from the prior-year period, driven by strong performance from Intuitive Surgical's gynecologic sector, which became its second largest surgical segment. Hysterectomy was the fastest growing procedure, VP-Business Development & Strategic Planning Aleks Cukic noted during firm's Q2 earnings call July 26. The largest gainer two years running on "The Gray Sheet" OTC index, Intuitive shipped 39 of its million-dollar-plus da Vinci systems during the quarter, bringing the number of worldwide installations to 467 (1"The Gray Sheet" Jan. 23, 2006, p. 13)...
Intuitive Surgical shows no slowing
Growth of robotic surgery systems firm continues to soar with second quarter sales of $87 mil., up 65% from the prior-year period, driven by strong performance from Intuitive Surgical's gynecologic sector, which became its second largest surgical segment. Hysterectomy was the fastest growing procedure, VP-Business Development & Strategic Planning Aleks Cukic noted during firm's Q2 earnings call July 26. The largest gainer two years running on "The Gray Sheet" OTC index, Intuitive shipped 39 of its million-dollar-plus da Vinci systems during the quarter, bringing the number of worldwide installations to 467 (1"The Gray Sheet" Jan. 23, 2006, p. 13)...
Boston Scientific Banks On ICDs To Spark Stock Growth; Index Slips In 2005
Boston Scientific is counting on Guidant shareholders preferring its takeover offer to J&J's to regain Wall Street enthusiasm in the face of diminishing competitive advantages for Taxus and a 31% stock decline in 2005